Nov 13 (Reuters)- Immuno Biological Laboratories Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 6 months ended 6 months ended Year to Sep 30, 2025 Sep 30, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 485 mln 444 mln 1.03 (+9.3 pct) (+21.5 pct) (+5.7 pct) Operating 142 mln 68 mln 240 mln (+109.0 pct) (+411.3 pct) (+14.6 pct) Recurring 149 mln 64 mln 240 mln (+133.4 pct) (+109.6 pct) (+14.4 pct) Net 141 mln 71 mln 265 mln (+98.0 pct) (+166.2 pct) (+6.4 pct) EPS 15.21 yen 7.68 yen 28.45 yen Ann Div NIL 6.00 yen -Q2 div NIL NIL -Q4 div NIL 6.00 yen NOTE - Immuno Biological Laboratories Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T